Evaluating quality of life in dermatomyositis

References

• Mammen AL. Dermatomyositis and polymyositis: clinical presentation, autoantibodies, and pathogenesis. Ann. NY Acad. Sci.1184, 134–153 (2010).
   PubMed Web of Science ®Google Scholar
• Carroll CL, Lang W, Snively B, Feldman SR, Callen J, Jorizzo JL. Development and validation of the Dermatomyositis Skin Severity Index. Br. J. Dermatol.158(2), 345–350 (2008).
   PubMed Web of Science ®Google Scholar
• Shirani Z, Kucenic MJ, Carroll CL et al. Pruritus in adult dermatomyositis. Clin. Exp. Dermatol.29, 273–276 (2004).
   PubMed Web of Science ®Google Scholar
• Jorizzo JL. Dermatomyositis: practical aspects. Arch. Dermatol.138(1), 114–116 (2002).
   PubMedGoogle Scholar
• Hundley JL, Carroll CL, Lang W et al. Cutaneous symptoms of dermatomyositis significantly impact patients’ quality of life. J. Am. Acad. Dermatol.54(2), 217–220 (2006).
   PubMed Web of Science ®Google Scholar
• Drouet B, Le Loët X, Vittecoq O et al. A study of long term survival, functional outcome and quality of life in patients with polymyositis or dermatomyositis. Rev. Rhum. Eng. Ed.63(5), 321–330 (1996).
   PubMedGoogle Scholar
• Goreshi R, Chock M, Fiorentino D, Feng R, Okawa J, Werth VP. Evaluating quality of life in dermatomyositis. J. Am. Acad. Dermatol. (2010) (In press).
   Google Scholar
• Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI): a simple practical measure for routine clinical use. Clin. Exp. Dermatol.19(3), 210–216 (1994).
   PubMed Web of Science ®Google Scholar
• Lewis V, Finlay AY. 10 years experience of the Dermatology Life Quality Index (DLQI). J. Investig. Dermatol. Symp. Proc.9(2), 169–180 (2004).
   PubMed Web of Science ®Google Scholar
• Chren MM, Lasek RJ, Quinn LM, Mostow EN, Zyzanski SJ. Skindex, a quality-of-life measure for patients with skin disease: reliability, validity, and responsiveness. J. Invest. Dermatol.107(5), 707–713 (1996).
   PubMed Web of Science ®Google Scholar
• Chren MM, Lasek RJ, Flocke SA, Zyzanski SJ. Improved discriminative and evaluative capability of a refined version of Skindex, a quality-of-life instrument for patients with skin diseases. Arch. Dermatol.133(11), 1433–1440 (1997).
   PubMed Web of Science ®Google Scholar
• Chren MM, Lasek RJ, Sahay AP, Sands LP. Measurement properties of Skindex-16: a brief quality-of-life measure for patients with skin diseases. J. Cutan. Med. Surg.5(2), 105–110 (2001).
   PubMed Web of Science ®Google Scholar
• Morgan M, McCreedy R, Simpson J, Hay RJ. Dermatology quality of life scales – a measure of the impact of skin diseases. Br. J. Dermatol.136(2), 202–206 (1997).
   PubMed Web of Science ®Google Scholar
• Anderson RT, Rajagopalan R. Development and validation of a quality of life instrument for cutaneous diseases. J. Am. Acad. Dermatol.37(1), 41–50 (1997).
   PubMed Web of Science ®Google Scholar
• Ware JE Jr, Sherbourne CD. The MOS 36-item Short-Form Survey (SF-36). I. Conceptual framework and item selection. Med. Care.30(6), 473–483 (1992).
   PubMed Web of Science ®Google Scholar
• McHorney CA, Ware JE Jr, Raczek AE. The MOS 36-item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity measuring physical and mental health constructs. Med. Care.31(3), 247–263 (1993).
   PubMed Web of Science ®Google Scholar
• Klein R, Moghadam-Kia S, Tylor L et al. Quality of life in cutaneous lupus erythematosus. J. Am. Acad. Dermatol. (2010) (In press).
   Google Scholar
• Jayaprakasam A, Darvay A, Osborne G, McGibbon D. Comparison of assessments of severity and quality of life in cutaneous diseases. Clin. Exp. Dermatol.27(4), 306–308 (2002).
   PubMed Web of Science ®Google Scholar
• Peloro TM, Miller OF 3rd, Hahn TF, Newman ED. Juvenile dermatomyositis: a retrospective review of a 30-year experience. J. Am. Acad. Dermatol.45(1), 28–34 (2001).
   PubMed Web of Science ®Google Scholar
• Bronner IM, van der Meulen MF, de Visser M et al. Long-term outcome in polymyositis and dermatomyositis. Ann. Rheum. Dis.65(11), 1456–1461 (2006).
   PubMed Web of Science ®Google Scholar
• Ponyi A, Borgulya G, Constantin T, Váncsa A, Gergely L, Dankó K. Functional outcome and quality of life in adult patients with idiopathic inflammatory myositis. Rheumatology (Oxford)44(1), 83–88 (2005).
   PubMed Web of Science ®Google Scholar
• Sultan SM, Ioannou Y, Moss K, Isenberg DA. Outcome in patients with idiopathic inflammatory myositis: morbidity and mortality. Rheumatology (Oxford)41(1), 22–26 (2002).
   PubMed Web of Science ®Google Scholar